ACTIVE

JOIN PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

41,3 k €

+45.4% YoY

Gross margin

21,5 k €

+42.3% YoY

Equity

569,1 k €

+7.8% YoY

What does JOIN PHARMA do?

JOIN PHARMA is a Private limited company incorporated in 2012. Its main activity is: Activities of holding companies. Its registered office is in Tervuren.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0846.679.346

Incorporation

18/06/2012

Legal form

Private limited company

Registered office

Lindenberg 16
3080 Tervuren · FlandreSee on map

Contributed capital

6 200,00 €

Latest accounts

31/12/2025

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies 68100Buying and selling of own real estate 68110Buying and selling of own real estate 68201Rental and operating of own or leased real estate 68201Rental and operating of own or leased real estate+2

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 13 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013
Income statement
Gross margin	21,5 k €	+42.3%	15,1 k €	+367%	3,2 k €	-72.5%	11,7 k €	-6.1%	12,5 k €	-3.6%	13 k €	+2.1%	12,7 k €	-1.5%	12,9 k €	+12.9%	11,4 k €	-36.2%	17,9 k €	-45.1%	32,7 k €	-24.4%	43,2 k €	-27.5%	59,6 k €
EBITDA	20,5 k €	+35.7%	15,1 k €	+386%	3,1 k €	-71.7%	10,9 k €	-11.4%	12,3 k €	-4.9%	13 k €	+2.1%	12,7 k €	-1.5%	12,9 k €	+12.9%	11,4 k €	-36.2%	17,9 k €	-45.1%	32,7 k €	-24.4%	43,2 k €	-27.5%	59,6 k €
Operating result	20,3 k €	+34.7%	15,1 k €	+399%	3 k €	-71.9%	10,7 k €	-6.9%	11,5 k €	-5.8%	12,2 k €	+1.2%	12,1 k €	-4.4%	12,7 k €	+13.2%	11,2 k €	-37.6%	17,9 k €	-44.9%	32,5 k €	-24.2%	42,9 k €	-27.4%	59,1 k €
Net result	41,3 k €	+45.4%	28,4 k €	-48.7%	55,4 k €	+6.3%	52,1 k €	+15.0%	45,4 k €	+23.8%	36,6 k €	+255%	10,3 k €	+0.9%	10,2 k €	+17.0%	8,8 k €	-76.6%	37,4 k €	-91.6%	446,8 k €	+3451%	12,6 k €	-74.9%	50,1 k €
Balance sheet
Equity	569,1 k €	+7.8%	527,8 k €	+3.9%	508,2 k €	+10.1%	461,6 k €	+10.9%	416,2 k €	+1.9%	408,3 k €	-27.1%	559,9 k €	-0.4%	562,1 k €	+1.9%	551,9 k €	+1.6%	543,1 k €	+7.4%	505,7 k €	+759%	58,9 k €	+27.2%	46,3 k €
Total assets	1,2 M €	+4.7%	1,1 M €	+1.7%	1,1 M €	+4.5%	1 M €	+1.8%	1 M €	-12.3%	1,2 M €	+2.7%	1,1 M €	+0.8%	1,1 M €	+1.1%	1,1 M €	-1.6%	1,1 M €	-0.1%	1,1 M €	-2.3%	1,2 M €	-2.4%	1,2 M €
Cash	21,1 k €	+127%	9,3 k €	-87.5%	74,1 k €	+6.5%	69,6 k €	-3.3%	71,9 k €	+13.5%	63,4 k €	+4.7%	60,5 k €	+90.0%	31,9 k €	+26.2%	25,2 k €	-39.0%	41,4 k €	-3.6%	42,9 k €	+2843%	1,5 k €	-96.3%	39,7 k €
Debts	599 k €	+1.9%	587,6 k €	-0.2%	588,7 k €	+0.2%	587,7 k €	-4.4%	614,4 k €	-19.9%	767,2 k €	+31.3%	584,2 k €	+2.1%	572,4 k €	+0.3%	570,9 k €	-4.4%	597,4 k €	-6.1%	636,5 k €	-42.6%	1,1 M €	-3.7%	1,2 M €

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Inge Annaert

Director · since 18 juin 2012

Active

Ended mandates

Inge Annaert

Manager · since 01 janvier 2013 · until 31 décembre 2018

Ended

Inge Annaert

Director

Ended

Inge Annaert

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
E & A FARMA● Active	0477.349.371

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	30/06/2025	05/07/2024	05/07/2023	30/07/2022	28/07/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	30/06/2023	30/06/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

13 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/06/2026	29/06/2026	Dutch	PDF
Abridged model	31/12/2024	27/06/2025	30/06/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	05/07/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	05/07/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	30/07/2022	Dutch	PDF
Abridged model	31/12/2020	25/06/2021	28/07/2021	Dutch	PDF
Abridged model	31/12/2019	26/06/2020	03/07/2020	Dutch	PDF
Abridged model	31/12/2018	28/06/2019	08/07/2019	Dutch	PDF
Abridged model	31/12/2017	29/06/2018	24/07/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	20/07/2017	Dutch	PDF
Abridged model	31/12/2015	24/06/2016	18/07/2016	Dutch	PDF
Abridged model	31/12/2014	26/06/2015	30/06/2015	Dutch	PDF
Abridged model	31/12/2013	27/06/2014	14/07/2014	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Inge Annaert

Director · since 18 juin 2012

Active

Ended mandates

Inge Annaert

Manager · since 01 janvier 2013 · until 31 décembre 2018

Ended

Inge Annaert

Director

Ended

Inge Annaert

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates23/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
PDF
Other28/06/2012
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202541,3 k €↑
2024
Annual accounts 202428,4 k €↓
2023
Annual accounts 202355,4 k €↑
2022
Annual accounts 202252,1 k €↑
2021
Annual accounts 202145,4 k €↑
2020
Annual accounts 202036,6 k €↑
2019
Annual accounts 201910,3 k €↑
2018
Annual accounts 201810,2 k €↑
2017
Annual accounts 20178,8 k €↓
2016
Annual accounts 201637,4 k €↓
2015
Annual accounts 2015446,8 k €↑
2014
Annual accounts 201412,6 k €↓
2013
Annual accounts 201350,1 k €
18/06/2012
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

JOIN PHARMA

Overview

What does JOIN PHARMA do?

Trend over 13 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline